ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,973Medicare Part D Prescriptions Filled, Including Refills

Rank: 69 out of 298

$347K Total Retail Price of All Prescriptions

Rank: 81 out of 298

422 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 422 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 422 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,296 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LISINOPRIL 353 331 1 4
LEVOTHYROXINE SODIUM 351 310 2 1
OMEPRAZOLE 297 272 3 3
SIMVASTATIN 243 234 4 2
WARFARIN SODIUM 215 177 5 7
FUROSEMIDE 202 202 6 5
HYDROCODONE-ACETAMINOPHEN 158 144 S3 7 8
METOPROLOL TARTRATE 151 146 8 9
AMLODIPINE BESYLATE 146 142 9 6
ATENOLOL 143 143 10 16
POTASSIUM CHLORIDE 139 138 11 11
SERTRALINE HCL 126 118 12 19
ALENDRONATE SODIUM 117 103 13 21
FENTANYL 114 113 S2 14 32
METFORMIN HCL 106 105 15 10
AZITHROMYCIN 100 96 16 63
TRAMADOL HCL-ACETAMINOPHEN 95 78 17 129
METOPROLOL SUCCINATE 88 60 18 12
DONEPEZIL HCL 88 88 18 22
POLYETHYLENE GLYCOL 3350 80 80 20 29
DIGOXIN 70 70 21 27
CITALOPRAM HBR 68 54 22 17
TRAMADOL HCL 67 57 23 15
CRESTOR 67 67 23 26
CLOPIDOGREL 62 55 25 36
GABAPENTIN 61 61 26 20
LOSARTAN POTASSIUM 61 56 26 18
LOSARTAN-HYDROCHLOROTHIAZIDE 61 58 26 44
BENAZEPRIL HCL 60 48 29 52
NOVOLOG 59 58 30 102
LANTUS 59 58 30 53
DIVALPROEX SODIUM 58 18 32 91
HYDROCHLOROTHIAZIDE 58 58 32 13
FENOFIBRATE 57 46 34 62
LEVOFLOXACIN 56 51 35 101
DILTIAZEM 24HR CD 54 54 36 74
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 53 36 30
CYCLOBENZAPRINE HCL 53 26 R 38 100
MELOXICAM 51 51 39 41
CEPHALEXIN 50 45 40 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.